RecruitingNot ApplicableNCT05766761

Reducing Alcohol Exposed Pregnancies

Designing a Hybrid Intervention Strategy to Reduce Alcohol Exposed Pregnancies


Sponsor

New York University

Enrollment

600 participants

Start Date

Apr 15, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to compare an active intervention versus a standard of care control in reducing alcohol use among pregnant women. The main questions it aims to answer are whether a motivational intervention can: 1. increase the proportion of women detected with a laboratory-confirmed negative phosphatidylethanol (PEth) test during pregnancy, and 2. reduce the proportion of adverse birth outcomes among infants. Participants will be offered (1) a self-paced computer-delivered alcohol reduction intervention to enhance knowledge, norms, and motivation for alcohol reduction and (2) a nurse-delivered component to reinforce the computer-delivered content and address women's questions. Both components are theory-driven, based on Motivational Enhancement Theory (MET), and use motivational strategies to promote alcohol reduction.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria3

  • years and above
  • Gestational age is 28 weeks or less
  • Recent alcohol use as assessed by self-report of alcohol use in the previous 30 days

Exclusion Criteria3

  • Under 18 years of age
  • Not pregnant or gestational age over 28 weeks
  • No recent alcohol use as assessed by self-report

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALIntervention condition, the usual prenatal care plus the alcohol intervention

The intervention is theory-driven, based on Motivational Enhancement Theory (MET), and uses motivational strategies to promote alcohol reduction.


Locations(1)

The University of Texas Health Science Center, Houston

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05766761


Related Trials